Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Renal Cell | 12 | 2024 | 3163 | 1.600 |
Why?
|
Kidney Neoplasms | 12 | 2024 | 4251 | 1.440 |
Why?
|
Nephrectomy | 3 | 2024 | 938 | 0.740 |
Why?
|
Quarantine | 1 | 2021 | 182 | 0.620 |
Why?
|
Drug Repositioning | 1 | 2019 | 233 | 0.550 |
Why?
|
Natural Language Processing | 3 | 2024 | 1163 | 0.540 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2019 | 664 | 0.520 |
Why?
|
Medical Oncology | 2 | 2024 | 2320 | 0.500 |
Why?
|
Infection Control | 1 | 2021 | 983 | 0.440 |
Why?
|
Electronic Health Records | 4 | 2024 | 4822 | 0.420 |
Why?
|
Blood Pressure Determination | 1 | 2015 | 633 | 0.370 |
Why?
|
Neoplasms | 7 | 2024 | 22142 | 0.330 |
Why?
|
Antihypertensive Agents | 1 | 2015 | 2019 | 0.250 |
Why?
|
Hypertension | 2 | 2015 | 8536 | 0.240 |
Why?
|
Androgen Antagonists | 2 | 2024 | 1408 | 0.230 |
Why?
|
Protein Kinase Inhibitors | 2 | 2023 | 5665 | 0.230 |
Why?
|
Overweight | 1 | 2015 | 2418 | 0.230 |
Why?
|
Prostatic Neoplasms | 3 | 2024 | 11101 | 0.220 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3493 | 0.200 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2021 | 3512 | 0.190 |
Why?
|
Disease-Free Survival | 2 | 2021 | 6819 | 0.170 |
Why?
|
Blood Pressure | 1 | 2015 | 8479 | 0.160 |
Why?
|
Clinical Trials, Phase III as Topic | 2 | 2021 | 858 | 0.160 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2576 | 0.160 |
Why?
|
Chemokine CXCL10 | 1 | 2019 | 309 | 0.150 |
Why?
|
Cisplatin | 1 | 2024 | 1652 | 0.150 |
Why?
|
Prognosis | 4 | 2024 | 29688 | 0.150 |
Why?
|
Body Mass Index | 1 | 2015 | 12952 | 0.140 |
Why?
|
ROC Curve | 1 | 2024 | 3584 | 0.130 |
Why?
|
Databases, Genetic | 1 | 2021 | 1741 | 0.120 |
Why?
|
Drug Approval | 1 | 2021 | 812 | 0.110 |
Why?
|
Humans | 27 | 2024 | 761222 | 0.110 |
Why?
|
Aged | 9 | 2024 | 169292 | 0.100 |
Why?
|
Systole | 1 | 2015 | 936 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1923 | 0.100 |
Why?
|
Male | 11 | 2024 | 360703 | 0.090 |
Why?
|
Immunotherapy | 3 | 2023 | 4642 | 0.090 |
Why?
|
Insulin Resistance | 1 | 2024 | 3952 | 0.090 |
Why?
|
Pyrimethamine | 1 | 2010 | 94 | 0.090 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 2010 | 132 | 0.090 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6304 | 0.080 |
Why?
|
Middle Aged | 8 | 2024 | 220858 | 0.080 |
Why?
|
Genetic Fitness | 1 | 2010 | 118 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4246 | 0.080 |
Why?
|
Predictive Value of Tests | 1 | 2024 | 15308 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2021 | 4574 | 0.070 |
Why?
|
Cohort Studies | 5 | 2024 | 41496 | 0.070 |
Why?
|
Time Factors | 2 | 2021 | 39957 | 0.070 |
Why?
|
Comorbidity | 1 | 2021 | 10516 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10218 | 0.060 |
Why?
|
Risk Factors | 4 | 2024 | 74241 | 0.060 |
Why?
|
Retrospective Studies | 6 | 2024 | 80675 | 0.060 |
Why?
|
Prospective Studies | 3 | 2024 | 54437 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8531 | 0.060 |
Why?
|
Female | 7 | 2024 | 392552 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5321 | 0.060 |
Why?
|
Antimalarials | 1 | 2010 | 907 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12676 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2023 | 7865 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 143 | 0.050 |
Why?
|
Mitosis | 1 | 2007 | 1187 | 0.050 |
Why?
|
Cell Death | 1 | 2007 | 1676 | 0.050 |
Why?
|
Tennessee | 1 | 2021 | 119 | 0.050 |
Why?
|
Evolution, Molecular | 1 | 2010 | 1882 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2007 | 1767 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2010 | 1740 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2021 | 9025 | 0.040 |
Why?
|
Adult | 4 | 2024 | 221120 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 518 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11733 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 632 | 0.040 |
Why?
|
Anilides | 1 | 2021 | 411 | 0.040 |
Why?
|
Creatinine | 1 | 2024 | 1897 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13632 | 0.040 |
Why?
|
Death | 1 | 2023 | 677 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13386 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39127 | 0.040 |
Why?
|
Tumor Burden | 1 | 2022 | 1892 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1783 | 0.030 |
Why?
|
Prostatectomy | 1 | 2024 | 1825 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1089 | 0.030 |
Why?
|
Body Composition | 1 | 2024 | 2427 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2058 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1662 | 0.030 |
Why?
|
Genes, Protozoan | 1 | 2010 | 170 | 0.020 |
Why?
|
Pyridines | 1 | 2021 | 2872 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2024 | 4947 | 0.020 |
Why?
|
Liver | 1 | 2024 | 7512 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3875 | 0.020 |
Why?
|
HCT116 Cells | 1 | 2007 | 405 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58952 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5755 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5829 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12728 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6988 | 0.020 |
Why?
|
Point Mutation | 1 | 2010 | 1593 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9278 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20118 | 0.010 |
Why?
|
Drug Resistance | 1 | 2010 | 1594 | 0.010 |
Why?
|
Genomic Instability | 1 | 2007 | 709 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24022 | 0.010 |
Why?
|
HeLa Cells | 1 | 2007 | 3073 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3430 | 0.010 |
Why?
|
Saccharomyces cerevisiae | 1 | 2010 | 2667 | 0.010 |
Why?
|
Alleles | 1 | 2010 | 6857 | 0.010 |
Why?
|
Mutation | 1 | 2022 | 30004 | 0.010 |
Why?
|
Young Adult | 1 | 2021 | 59222 | 0.010 |
Why?
|
United States | 1 | 2021 | 72341 | 0.010 |
Why?
|
Adolescent | 1 | 2021 | 88300 | 0.010 |
Why?
|
Phenotype | 1 | 2010 | 16575 | 0.010 |
Why?
|
Concepts
(110)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(90)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_